Drug Profile
GCWB 204
Alternative Names: BST 204; GCWB204Latest Information Update: 28 Jul 2022
Price :
$50
*
At a glance
- Originator Green Cross Health Science
- Developer Green Cross Wellbeing
- Class Antineoplastics; Ginsenosides; Saponins
- Mechanism of Action Interleukin 6 inhibitors; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Cachexia